Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.2K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.0K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.0K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

644
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
644
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

518
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
518
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

764
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same author

Across Clinical Profiles of Cardiorenal-Metabolic (CKM) Syndrome: A Phenotype-Driven Therapeutic Approach.

Biomedicines·2026
Same author

Genomic and proteogenomic insights into Spontaneous Coronary Artery Dissection (SCAD): A systematic review of emerging multi-omic evidence.

Vascular pharmacology·2026
Same author

The spectrum of congestion in heart failure: underlying pathophysiology and diagnostic strategies.

Heart failure reviews·2026
Same author

A TRIP-nano killer silencing the pain pacemakers.

The Journal of physiology·2026
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same journal

Mechanistic factors of cardiovascular diseases.

Minerva cardioangiologica·2020
Same journal

Robotic-assisted coronary artery bypass grafting: current knowledge and future perspectives.

Minerva cardioangiologica·2020
Same journal

Features of degenerative mitral valve prolapse in the North East of China: repair characteristics, and short-term follow-up results.

Minerva cardioangiologica·2020
Same journal

Myocardial revascularization in chronic coronary syndromes: does viability matter?

Minerva cardioangiologica·2020
Same journal

Extracorporeal membrane oxygenation for COVID-19: effective weapon or futile effort?

Minerva cardioangiologica·2020
Same journal

Heart and endurance sports: excesses are often unhealthy.

Minerva cardioangiologica·2020
See all related articles

Related Experiment Video

Updated: Feb 23, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K

Resistant hypertension: an overview.

Roberto Pedrinelli1, Giulia Dell'omo2, Matteo Cameli3

  • 1Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy - roberto.pedrinelli@med.unipi.it.

Minerva Cardioangiologica
|September 8, 2017
PubMed
Summary
This summary is machine-generated.

Resistant hypertension (RH) affects many patients despite available treatments. Accurate diagnosis requires ambulatory blood pressure monitoring, and while new treatments are explored, RH significantly increases cardiovascular risk.

More Related Videos

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

789
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.3K

Related Experiment Videos

Last Updated: Feb 23, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.3K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

789
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

23.3K

Area of Science:

  • Cardiology
  • Nephrology
  • Pharmacology

Background:

  • Many patients with hypertension do not achieve target blood pressure (BP) levels despite effective medications.
  • A subset of patients presents with resistant hypertension (RH), defined as uncontrolled BP despite optimal treatment with multiple antihypertensive agents.
  • Accurate diagnosis of RH is crucial as it is associated with increased cardiovascular and cerebrovascular risk.

Purpose of the Study:

  • To review the definition, diagnosis, and management of resistant hypertension (RH).
  • To discuss the role of ambulatory blood pressure monitoring in confirming RH and excluding white-coat hypertension.
  • To highlight current therapeutic strategies and emerging interventions for RH.

Main Methods:

  • Review of current guidelines and literature on resistant hypertension.
  • Emphasis on the diagnostic criteria for RH, including the necessity of 24-hour ambulatory blood pressure monitoring.
  • Discussion of evidence-based treatment strategies, including standardized combination therapy and interventional procedures.

Main Results:

  • Resistant hypertension (RH) is diagnosed when office BP remains above goal despite the use of at least three antihypertensive medications, including a diuretic, at maximally tolerated doses.
  • Ambulatory blood pressure monitoring is essential to confirm RH and differentiate it from white-coat hypertension.
  • Standardized combination therapy is recommended, with spironolactone as a preferred fourth-line agent. Renal denervation has shown limited success.

Conclusions:

  • Resistant hypertension (RH) is a significant clinical challenge associated with elevated cardiovascular and cerebrovascular risk.
  • Accurate diagnosis using ambulatory blood pressure monitoring is critical.
  • Optimal medical management, including combination therapy, is the cornerstone of RH treatment, with ongoing research into novel interventions.